换一批Aberrant FAM135B attenuates the efficacy of chemotherapy in colorectal cancer by modulating SRSF1-mediated alternative splicing.
第一作者：
Wanmei,Lin
第一单位：
The First School of Clinical Medicine, Southern Medical University, Guangzhou, China.;Department of Pathology, Guangdong Province Key Laboratory of Molecular Tumor Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
作者：
医学主题词
人类(Humans);结直肠肿瘤(Colorectal Neoplasms);选择性剪接(Alternative Splicing);动物(Animals);小鼠(Mice);DNA修复(DNA Repair);细胞系, 肿瘤(Cell Line, Tumor);抗药性, 肿瘤(Drug Resistance, Neoplasm);抗肿瘤药(Antineoplastic Agents);细胞增殖(Cell Proliferation);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic)
DOI
10.1038/s41388-024-03189-9
PMID
39397154
发布时间
2026-03-25
- 浏览0
Oncogene
3532-3544页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
